April 04, 2019
Rose
House Energy and Commerce Committee Chairman Frank Pallone Jr. (D-N.J.) and Rep. Greg Walden (R-Ore.) have reached a key agreement over the measure. Aides in both parties said Democrats verbally agreed to make changes to one of the most prominent measures, known as the Creates Act, which cracks down on tactics drug companies use to delay the introduction of cheaper generic drugs.
from Kaiser Health News https://ift.tt/2YXK1Gy
April 04, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
California Lawmakers Debate Sending Local Health Inspectors Into Immigration Facilities- Journalists Drill Down on Ongoing Covid Risks, Escalating Health Care Costs
- Maternity Care in Rural Areas Is in Crisis. Can More Doulas Help?
- It’s a Bird. It’s a Plane. It’s a Medical Response Drone.
- Readers Weigh In on the Abortion Debate and Ways To Tackle the Opioid Crisis
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment